Oct. 21, 2024
| Today’s news and insights for medtech leaders
Deep Dive
Laboratories face a series of upcoming deadlines to comply with stricter FDA oversight of in-house tests. Here are five strategies labs can take to be ready.
|
Stifel analyst Rick Wise said Boston Scientific can now offer “one-stop-shopping” with a pulsed field ablation catheter and integrated mapping system to treat atrial fibrillation.
|
After a February recall, Boston Scientific has warned physicians about new safety risks for Obsidio Embolic, which is now connected to a total of 15 injuries and four deaths.
|
Without a cohesive procurement strategy, biopharma organizations risk costly oversights, stakeholder frustrations, and disorganization. Learn how biopharma leaders are overcoming these challenges in
|
Alongside immunotherapy or chemo, the wearable device helped patients live longer in a trial, though the results are somewhat controversial.
|
Former CDRH leader Jeff Shuren told an audience at The Medtech Conference that Michelle Tarver “will make an excellent center director, and quite frankly, the best is yet to come.”
|
BTIG analysts wrote that installations of Intuitive’s new robotic surgery system are “well ahead of lofty” expectations.
|
|
The medical device recall process has faced scrutiny over the past several years after product safety issues have landed in the public spotlight. Explore top product safety protocols in this Trendline.
|
|
From Our Library
Webinar - on demand
Custom content for Singapore Economic Development Board
|
Webinar - on demand
Custom content for Avery Dennison
|
| 
